Responses
Research ethics
The use of placebo in a trial of rectal artesunate as initial treatment for severe malaria patients en route to referral clinics: ethical issues
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 30 June 2010
- Published on: 30 June 2010Lack of alternative to rectal artesunate for pre-referral treatment of malaria ? Rectal quinine as an available and effective health toolShow More
In developing countries, most cases of malaria occur in rural areas far from hospitals, where health care providers cannot adequately manage severe malaria cases. Hospital referral causes treatment delays. Most deaths occur during the first 24 hours, highlighting the need for earlier actions to reduce mortality. Gomes and colleagues reported recently the benefits of pre-referral rectal artesunate.(1) A single pre-referra...
Conflict of Interest:
None declared.
Other content recommended for you
- Geographical concentration of falciparum malaria treated in the UK and delay to treatment with artesunate in severe cases: an observational study
- Malaria
- Stopping prereferral rectal artesunate — a grave error
- Prognostic models for the clinical management of malaria and its complications: a systematic review
- UK treatment of malaria
- The treatment of imported malaria in children: an update
- Delayed autoimmune haemolytic anaemia after artesunate therapy for severe malaria
- Artemisinins in malaria treatment in the UK
- Malaria: an update on treatment of adults in non-endemic countries
- Artemisinins